280 related articles for article (PubMed ID: 27899748)
1. Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.
Bravo-Ferrer I; Cuartero MI; Zarruk JG; Pradillo JM; Hurtado O; Romera VG; Díaz-Alonso J; García-Segura JM; Guzmán M; Lizasoain I; Galve-Roperh I; Moro MA
Stroke; 2017 Jan; 48(1):204-212. PubMed ID: 27899748
[TBL] [Abstract][Full Text] [Related]
2. Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.
Ramirez SH; Haskó J; Skuba A; Fan S; Dykstra H; McCormick R; Reichenbach N; Krizbai I; Mahadevan A; Zhang M; Tuma R; Son YJ; Persidsky Y
J Neurosci; 2012 Mar; 32(12):4004-16. PubMed ID: 22442067
[TBL] [Abstract][Full Text] [Related]
3. A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo.
Lunn CA; Fine JS; Rojas-Triana A; Jackson JV; Fan X; Kung TT; Gonsiorek W; Schwarz MA; Lavey B; Kozlowski JA; Narula SK; Lundell DJ; Hipkin RW; Bober LA
J Pharmacol Exp Ther; 2006 Feb; 316(2):780-8. PubMed ID: 16258021
[TBL] [Abstract][Full Text] [Related]
4. Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice.
Espinera AR; Ogle ME; Gu X; Wei L
Neuroscience; 2013 Sep; 247():1-11. PubMed ID: 23590907
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA
Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035
[TBL] [Abstract][Full Text] [Related]
6. Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway.
Dhopeshwarkar A; Mackie K
J Pharmacol Exp Ther; 2016 Aug; 358(2):342-51. PubMed ID: 27194477
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.
Curto-Reyes V; Boto T; Hidalgo A; Menéndez L; Baamonde A
Eur J Pharmacol; 2011 Oct; 668(1-2):184-9. PubMed ID: 21771590
[TBL] [Abstract][Full Text] [Related]
8. Time-Dependent Protection of CB2 Receptor Agonist in Stroke.
Yu SJ; Reiner D; Shen H; Wu KJ; Liu QR; Wang Y
PLoS One; 2015; 10(7):e0132487. PubMed ID: 26186541
[TBL] [Abstract][Full Text] [Related]
9. Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity.
Sun L; Dong R; Xu X; Yang X; Peng M
J Neuroinflammation; 2017 Jul; 14(1):138. PubMed ID: 28724382
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate Kinase M2 Increases Angiogenesis, Neurogenesis, and Functional Recovery Mediated by Upregulation of STAT3 and Focal Adhesion Kinase Activities After Ischemic Stroke in Adult Mice.
Chen D; Wei L; Liu ZR; Yang JJ; Gu X; Wei ZZ; Liu LP; Yu SP
Neurotherapeutics; 2018 Jul; 15(3):770-784. PubMed ID: 29869055
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats.
Fujii M; Sherchan P; Krafft PR; Rolland WB; Soejima Y; Zhang JH
J Neurol Sci; 2014 Jul; 342(1-2):101-6. PubMed ID: 24819918
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.
Amenta PS; Jallo JI; Tuma RF; Hooper DC; Elliott MB
J Neuroinflammation; 2014 Nov; 11():191. PubMed ID: 25416141
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats.
Fujii M; Sherchan P; Soejima Y; Doycheva D; Zhao D; Zhang JH
Acta Neurochir Suppl; 2016; 121():135-9. PubMed ID: 26463937
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 4 modulates cell migration and cortical neurogenesis after focal cerebral ischemia.
Moraga A; Pradillo JM; Cuartero MI; Hernández-Jiménez M; Oses M; Moro MA; Lizasoain I
FASEB J; 2014 Nov; 28(11):4710-8. PubMed ID: 25063846
[TBL] [Abstract][Full Text] [Related]
15. Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.
Powers MS; Breit KR; Chester JA
Alcohol Clin Exp Res; 2015 Dec; 39(12):2438-46. PubMed ID: 26756798
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model.
Tao Y; Tang J; Chen Q; Guo J; Li L; Yang L; Feng H; Zhu G; Chen Z
Brain Res; 2015 Mar; 1602():127-35. PubMed ID: 25625355
[TBL] [Abstract][Full Text] [Related]
18. Poststroke Sonic Hedgehog Agonist Treatment Improves Functional Recovery by Enhancing Neurogenesis and Angiogenesis.
Jin Y; Barnett A; Zhang Y; Yu X; Luo Y
Stroke; 2017 Jun; 48(6):1636-1645. PubMed ID: 28487338
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Neurogenesis and Collaterogenesis by Sodium Danshensu Treatment After Focal Cerebral Ischemia in Mice.
Wei ZZ; Chen D; Liu LP; Gu X; Zhong W; Zhang YB; Wang Y; Yu SP; Wei L
Cell Transplant; 2018 Apr; 27(4):622-636. PubMed ID: 29984620
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice.
Ueda Y; Miyagawa N; Wakitani K
Life Sci; 2007 Jan; 80(5):414-9. PubMed ID: 17055000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
